{"id":108,"date":"2013-09-11T13:32:47","date_gmt":"2013-09-11T11:32:47","guid":{"rendered":"http:\/\/www.mk-stracon.com\/?page_id=108"},"modified":"2020-01-27T12:25:46","modified_gmt":"2020-01-27T10:25:46","slug":"events","status":"publish","type":"page","link":"https:\/\/www.mk-stracon.com\/?page_id=108","title":{"rendered":"Presentations"},"content":{"rendered":"

Liquid Biopsy Summit
\n(Lisbon, February 20, 2020)<\/strong><\/p>\n

Presentation “Liquid biopsies: Coming of age of promising tools”<\/p>\n

\n

Can<\/strong>ce<\/strong>r Precision Medicine Forum
\n(Berlin, December 2, 2019)<\/strong><\/p>\n

Panel discussion: \u201eExamining the influence of current regulatory & policy frameworks in facilitating the progress & implementation of Precision Oncology\u201c<\/p>\n

\n

2nd Annual Companion Diagnostics & Biomarker Conference
\n(Porto, February 14, 2019)<\/strong><\/p>\n

Panel discussion: “Regulation of CDx in the EU”<\/p>\n

\n

Biotech Pharma Summit 2017
\n(Porto, October 26, 2017)<\/strong><\/p>\n

Presentation: “Case Study Companion Diagnostics”<\/p>\n

\n

Nordic Precision Medicine Forum
\n(Copenhagen, April 26, 2017)<\/strong><\/p>\n

Presentation: “Companion Diagnostics – recent advantages and future perspectives\u201d<\/p>\n

\n

Pharma Danmark Conference
\n(Copenhagen, November 5, 2016)<\/strong><\/p>\n

Presentation: “Personalized Medicine – recent advantages and future perspectives\u201d<\/p>\n

\n

Medtech & Pharma Platform “Inovative drug-device combinations and diagnostics”
\n(Basel, September 22-23, 2016)<\/strong><\/p>\n

Presentation: “Companion diagnostics development – current status & future perspective”\u201d<\/p>\n

\n

Precision Medicine Congress
\n(London, September 12-13, 2016)<\/strong><\/p>\n

Panel Discussion: “Advancing Precision Medicine, including NGS, in the Evolving Regulatory Environment\u201d<\/p>\n

\n

World CDx Conference
\n(London, March 15-17, 2016)<\/strong><\/p>\n

Workshop: Drug-Companion Diagnostic Adoption & Reimbursement: “A Comprehensive Guide to the Major European States”<\/p>\n

Panel Discussion: “How do we Deal with the Ever-Changing Regulatory Landscape?\u201d<\/p>\n

\n

Precision Medicine Congress
\n(London, September 14-15, 2015)<\/strong><\/p>\n

Panel discussion: “Future of Precision Medicine”<\/p>\n

\n

World<\/strong> CDx Conference
\n(Berlin, March 17-19, 2015)<\/strong><\/p>\n

Workshop: \u201cOperational Management of a CDx program: A comprehensive guide to the major regulatory landscapes”<\/p>\n

\n

SBA Academy “Changing paradigms in drug development”
\n(Bern, February 3, 2015)<\/strong><\/p>\n

Presentation: “Personalized medicine – changing the way drugs are developed and used”<\/p>\n

\n

Precision Medicine Congress
\n(London, May 19-20, 2014)<\/strong><\/p>\n

Panel discussion: \u201cChoosing & Managing RxDx partnerships”<\/p>\n

\n

CHI Web Training Course “Use of Companion Diagnostics for Driving Precision Medicine in CNS Disorders”
\n(April 10, 2014)<\/strong><\/p>\n

Presentation: “CDx Regulatory Framework: Lessons Learned From Oncology”<\/p>\n

\n

BioM<\/sup> m4 Strategy Workshop
\n(Munich, March 19-20, 2014)<\/strong><\/p>\n

Presentation: \u201cPersonalised Medicine – a new paradigm in healthcare”<\/p>\n

\n

ADAPT Congress Global Strategies for Companion Diagnostics
\n(Boston, Nov.ember 4\u20135, 2013)<\/strong><\/p>\n

Presentation: \u201cThe Economic Value within Companion Diagnostics and Stratified Medicines Relationships\u201d<\/p>\n

\n

Sachs Annual Biotech in Europe Investor Forum
\n(Zurich, September 30\u20130ct. 1, 2013)<\/strong><\/p>\n

Panel Discussion: \u201cPersonalised Medicine and Companion Diagnostics: from development to market\u201d<\/p>\n

\n

Oncotest Symposium
\n<\/strong>(Freiburg, April 25\u201316, 2013)<\/strong><\/p>\n

Presentation: \u201cOvercoming practical hurdles related to the operationalization of Personalized Medicine clinical trials\u201d<\/p>\n

\n

Sachs European Lifescience CEO Forum
\n<\/strong>(Zurich, March 5\u20136, 2013)<\/strong><\/p>\n

Presentation: \u201cRegenerative medicine \u2013 on the cutting edge of healthcare and personalised medicine\u201d<\/p>\n

\n

M4\u00a0<\/sup>Biomarker Conference
\n<\/strong>(Munich, November 22\u201323, 2012)<\/strong><\/p>\n

Panel Discussion: \u201cMolecular imaging for personalized medicine: a doubtful future?\u201c<\/p>\n

>> LECTURES<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Liquid Biopsy Summit (Lisbon, February 20, 2020) Presentation “Liquid biopsies: Coming of age of promising tools” Cancer Precision Medicine Forum (Berlin, December 2, 2019) Panel discussion: \u201eExamining the influence of current regulatory & policy frameworks in facilitating the progress &…<\/span><\/p>\n

Read more ›<\/a><\/div>\n

<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/pages\/108"}],"collection":[{"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=108"}],"version-history":[{"count":31,"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/pages\/108\/revisions"}],"predecessor-version":[{"id":232,"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=\/wp\/v2\/pages\/108\/revisions\/232"}],"wp:attachment":[{"href":"https:\/\/www.mk-stracon.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}